Authors: Zilberman-Itskovich S, Catalogna M, Sasson E, Hadanny A, Lang E, Finci S et al. PMID: 36261911 DOI: 10.1097/01.NAJ.0000897152.36663.7a Abstract According to this study: Hyperbaric oxygen therapy can improve cognitive function, psychiatric symptoms, pain, and fatigue in patients who have post-COVID-19 condition.The beneficial effect of the therapy can be attributed to increased brain perfusion and [...]

Authors: Robbins T, Gonevski M, Clark C, Sharma K, Magar A PMID: 34862223 PMCID: PMC8806311 DOI: 10.7861/clinmed.2021-0462 Abstract Background: Long COVID is a common occurrence following COVID-19 infection. The most common symptom reported is fatigue. Limited interventional treatment options exist. We report the first evaluation of hyperbaric oxygen therapy (HBOT) for long COVID treatment. Methods: [...]

Authors: Oliaei S, Mehrtak M, Karimi A, Noori T, Shojaei A, Dadras O PMID: 34412709 PMCID: PMC8374420 DOI: 10.1186/s40001-021-00570-2 Abstract Background: Oxygenation serves as a cornerstone in the treatment of COVID-19, and several methods have been extensively studied so far. Herein, we aimed to systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine [...]

Authors: Senniappan K, Jeyabalan S, Rangappa P, Kanchi M PMID: 33437070 PMCID: PMC7791429 DOI: 10.4103/ija.IJA_613_20 Abstract The coronavirus disease 2019 (COVID-19) is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Although 85% of infected patients remain asymptomatic, 5% show severe symptoms such as hypoxaemic respiratory failure and multiple end organ dysfunction (MODS) [...]

Authors: Kjellberg A, De Maio A, Lindholm P PMID: 33254531 PMCID: PMC7456590 DOI: 10.1016/j.mehy.2020.110224 Abstract Introduction: SARS-CoV-2 affects part of the innate immune response and activates an inflammatory cascade stimulating the release of cytokines and chemokines, particularly within the lung. Indeed, the inflammatory response during COVID-19 is likely the cause for the development of acute [...]

Authors: De Maio A, Hightower LE PMID: 32424591 PMCID: PMC7232923 DOI: 10.1007/s12192-020-01121-0 Abstract The current coronavirus disease 2019 (COVID-19) pandemic has become an unprecedented challenge for the healthcare system worldwide, with an overwhelming number of patients requiring clinical attention and an unacceptably high mortality rate within critical care facilities. COVID-19 is caused by a novel [...]

Authors: Tezgin D, Giardina C, Perdrizet GA, Hightower LE PMID: 32253741 PMCID: PMC7332662 doi: 10.1007/s12192-020-01100-5 Abstract We present new data on the effects of HBOT on human kidney (HK-2) cell metabolism using a SeaHorse XF Analyzer to evaluate separately the state of mitochondrial and glycolytic energy metabolism. The data are discussed in the context of [...]

Authors: Hadanny A, Abbott S, Suzin G, Bechor Y, Efrati S PMID: 30269074 PMCID: PMC6169752 DOI: 10.1136/bmjopen-2018-023387 Abstract Objectives: The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) in participants suffering from chronic neurological deficits due to traumatic brain injury (TBI) of all severities in [...]

Authors: Buras JA, Holt D, Orlow D, Belikoff B, Pavildes S, Reenstra WR PMID: 16932233 DOI: 10.1097/01.CCM.0000239438.22758.E0 Abstract Objective: This study was performed to determine whether hyperbaric oxygen (HBO2) therapy is protective in cecal ligation and puncture (CLP)-induced sepsis and if protection is dependent on oxygen dosing. We also wished to determine whether HBO2 affected [...]